Interestingly, we found that CTHRC1, NTM, PDGFC, PDLIM3, and SLC16A3 are gradually upregulated from normal to a metastatic tumor, indicating the association of these genes in tumor progression (Welch’s t-test, p < 0.05) (Figure 7). This evidence concerns the gene PDLIM3 and metastatic neoplasm.